Abstract | OBJECTIVES: METHODS: RESULTS: We demonstrated that the presence of PVL was associated with IL-1β and IL-8 release in the lung. During PVL-mediated sterile pneumonia, Kineret/IL-1Ra reduced IL-8 production indicating the relevance of the PVL/IL-1/IL-8 cascade in vivo and the potential of Kineret/IL-1Ra to reduce lung inflammation. However, Kineret/IL-1Ra was ineffective in blocking IL-8 production during infection with S. aureus. Furthermore, treatment with Kineret increased the bacterial burden in the lung. CONCLUSIONS: Our data demonstrate PVL-dependent inflammasome activation during S.aureus pneumonia, indicate that IL-1 signaling controls bacterial burden in the lung and suggest that therapy aimed at targeting this pathway might be deleterious during pneumonia.
|
Authors | Delphine Labrousse, Magali Perret, Davy Hayez, Sonia Da Silva, Cédric Badiou, Florence Couzon, Michèle Bes, Pascal Chavanet, Gérard Lina, François Vandenesch, Delphine Croisier-Bertin, Thomas Henry |
Journal | PloS one
(PLoS One)
Vol. 9
Issue 6
Pg. e97546
( 2014)
ISSN: 1932-6203 [Electronic] United States |
PMID | 24905099
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Bacterial Toxins
- Exotoxins
- Inflammasomes
- Interleukin 1 Receptor Antagonist Protein
- Interleukin-1beta
- Interleukin-8
- Leukocidins
- Panton-Valentine leukocidin
|
Topics |
- Animals
- Bacterial Toxins
(toxicity)
- Exotoxins
(toxicity)
- Inflammasomes
(drug effects, immunology)
- Interleukin 1 Receptor Antagonist Protein
(pharmacology, therapeutic use)
- Interleukin-1beta
(metabolism)
- Interleukin-8
(metabolism)
- Leukocidins
(toxicity)
- Macrophages
(drug effects, immunology)
- Pneumonia, Staphylococcal
(drug therapy, etiology, metabolism)
- Rabbits
|